{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:33:55Z","timestamp":1791192835796,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.cyto.2012.06.015","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T20:01:56Z","timestamp":1340913716000},"page":"460-466","source":"Crossref","is-referenced-by-count":14,"title":["Interferon signaling in the liver during hepatitis C virus infection"],"prefix":"10.1016","volume":"59","author":[{"given":"Zuzanna","family":"Makowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus H.","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2012.06.015_b0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cyto.2012.06.015_b0010","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1086\/375350","article-title":"Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection","volume":"187","author":"Goutagny","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cyto.2012.06.015_b0020","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cyto.2012.06.015_b0025","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.cyto.2012.06.015_b0030","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2012.06.015_b0035","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2012.06.015_b0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cyto.2012.06.015_b0045","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1128\/JVI.76.12.5974-5984.2002","article-title":"Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex","volume":"76","author":"Egger","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0050","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1128\/JVI.77.9.5487-5492.2003","article-title":"Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons","volume":"77","author":"Gosert","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0055","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1073\/pnas.94.4.1200","article-title":"Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets","volume":"94","author":"Barba","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.06.015_b0060","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.82898-0","article-title":"Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus","volume":"88","author":"Boulant","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0065","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production","volume":"9","author":"Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.cyto.2012.06.015_b0070","doi-asserted-by":"crossref","first-page":"16850","DOI":"10.1074\/jbc.M802273200","article-title":"Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production","volume":"283","author":"Targett-Adams","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.06.015_b0075","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1128\/JVI.01565-07","article-title":"Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication","volume":"82","author":"Targett-Adams","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0080","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-density hepatitis C virus RNA-containing particles","volume":"76","author":"Andr\u00e9","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0085","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1128\/JVI.01150-06","article-title":"Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles","volume":"80","author":"Gastaminza","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0090","doi-asserted-by":"crossref","first-page":"18666","DOI":"10.1073\/pnas.0708423104","article-title":"Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.06.015_b0095","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2012.06.015_b0100","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1128\/JVI.73.4.3317-3325.1999","article-title":"Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus","volume":"73","author":"Major","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0105","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1086\/315450","article-title":"Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C","volume":"181","author":"Gr\u00fcner","year":"2000","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.cyto.2012.06.015_b0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2893.1999.00006.x","article-title":"Role of the specific T-cell response for clearance and control of hepatitis C virus","volume":"6","author":"Pape","year":"1999","journal-title":"J Viral Hepatitis"},{"key":"10.1016\/j.cyto.2012.06.015_b0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jmv.10448","article-title":"Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study","volume":"71","author":"Watanabe","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C","volume":"132","author":"Liang","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cyto.2012.06.015_b0125","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0130","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0135","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","article-title":"Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection","volume":"360","author":"McHutchison","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.06.015_b0140","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1010494","article-title":"Boceprevir for untreated chronic HCV genotype 1 infection","volume":"364","author":"Poordad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.06.015_b0145","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/JVI.74.4.2046-2051.2000","article-title":"Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3\u2032 nontranslated region are essential for virus replication in vivo","volume":"74","author":"Kolykhalov","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.06.015_b0155","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0808010","article-title":"Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection","volume":"361","author":"McHutchison","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.06.015_b0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cyto.2012.06.015_b0165","doi-asserted-by":"crossref","first-page":"15315","DOI":"10.1074\/jbc.R700007200","article-title":"Function of RIG-I-like receptors in antiviral innate immunity","volume":"282","author":"Yoneyama","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.06.015_b0170","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2012.06.015_b0175","first-page":"641","article-title":"Gamma-interferon production by human low-density lymphocytes induced by T-cell mitogens","volume":"58","author":"Croll","year":"1986","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2012.06.015_b0180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4049\/jimmunol.130.2.988","article-title":"Natural killer (NK) cells as a responder to interleukin 2 (IL 2) II IL 2-induced interferon gamma production","volume":"130","author":"Handa","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.06.015_b0185","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1172\/JCI113911","article-title":"Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production","volume":"83","author":"Kurane","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2012.06.015_b0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","article-title":"The IFN gamma receptor: a paradigm for cytokine receptor signaling","volume":"15","author":"Bach","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cyto.2012.06.015_b0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2012.06.015_b0200","doi-asserted-by":"crossref","unstructured":"Sommereyns C, Paul S, Staeheli P, Michiels T. IFN-lambda (IFN-\u03bb) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 2008;4.","DOI":"10.1371\/journal.ppat.1000017"},{"key":"10.1016\/j.cyto.2012.06.015_b0205","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/j.1460-2075.1991.tb08026.x","article-title":"Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor","volume":"10","author":"Decker","year":"1991","journal-title":"EMBO J"},{"key":"10.1016\/j.cyto.2012.06.015_b0210","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1093\/nar\/20.15.3865","article-title":"Transcriptional induction of IFN-gamma-responsive genes is modulated by DNA surrounding the interferon stimulation response element","volume":"20","author":"Strehlow","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cyto.2012.06.015_b0215","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/MCB.11.10.5147","article-title":"Two distinct alpha-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene","volume":"11","author":"Decker","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cyto.2012.06.015_b0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/j.1460-2075.1994.tb06245.x","article-title":"Tyrosine phosphorylated p91 binds to a single element in the ISGF2\/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene","volume":"13","author":"Pine","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.cyto.2012.06.015_b0225","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1101\/gad.4.10.1753","article-title":"Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator","volume":"4","author":"Kessler","year":"1990","journal-title":"Genes Dev"},{"key":"10.1016\/j.cyto.2012.06.015_b0230","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons \u03b1 and \u03bb Inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2012.06.015_b0235","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon \u03b1, \u03b2, or \u03b3 using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.06.015_b0240","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/hep.21167","article-title":"Genomic response to interferon-\u03b1 in chimpanzees: implications of rapid downregulation for hepatitis C kinetics","volume":"43","author":"Lanford","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0245","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/MCB.00224-09","article-title":"Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18\/UBP43","volume":"29","author":"Sarasin-Filipowicz","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cyto.2012.06.015_b0250","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0021-9258(17)42492-6","article-title":"Transcriptional induction by interferon. New protein(s) determine the extent and length of the induction","volume":"261","author":"Larner","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cyto.2012.06.015_b0255","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0092-8674(84)90270-8","article-title":"Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells","volume":"38","author":"Friedman","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2012.06.015_b0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ni1287","article-title":"Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity","volume":"7","author":"Fenner","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2012.06.015_b0265","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.emboj.7601149","article-title":"UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity","volume":"25","author":"Malakhova","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.cyto.2012.06.015_b0270","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.178.8.4832","article-title":"IFN-\u03b1-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins","volume":"178","author":"Zimmerer","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.06.015_b0275","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.24189","article-title":"Interferon-\u03b2 and interferon-\u03bb signaling is not affected by interferon-induced refractoriness to interferon-\u03b1 in vivo","volume":"53","author":"Makowska","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0280","doi-asserted-by":"crossref","unstructured":"Fran\u00e7ois-Newton V, Magno de Freitas Almeida G, Payelle-Brogard B, Monneron D, Pichard-Garcia L, Piehler J, et al. USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon \u03b1 response. PLoS ONE 2011;6:e22200.","DOI":"10.1371\/journal.pone.0022200"},{"key":"10.1016\/j.cyto.2012.06.015_b0285","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmb.2006.11.053","article-title":"Differential receptor subunit affinities of type I interferons govern differential signal activation","volume":"366","author":"Jaks","year":"2007","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cyto.2012.06.015_b0290","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2012.06.015_b0295","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.06.015_b0300","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/gut.2007.128611","article-title":"Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C","volume":"57","author":"Asselah","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2012.06.015_b0305","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2009.11.004","article-title":"Hepatitis C virus blocks interferon effector function by inducing protein kinase r phosphorylation","volume":"6","author":"Garaigorta","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cyto.2012.06.015_b0310","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9440(10)63673-5","article-title":"Dynamics of hepatitis C virus replication in human liver","volume":"163","author":"Chang","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2012.06.015_b0315","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/j.gastro.2009.07.050","article-title":"Visualizing hepatitis C virus infections in human liver by two-photon microscopy","volume":"137","author":"Liang","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2012.06.015_b0320","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/JVI.80.5.2280-2290.2006","article-title":"Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo","volume":"80","author":"Pal","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0325","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.73.10.8469-8475.1999","article-title":"Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway","volume":"73","author":"Heim","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0330","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.gastro.2003.10.076","article-title":"Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A","volume":"126","author":"Duong","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2012.06.015_b0335","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.21611","article-title":"Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A","volume":"46","author":"Christen","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0340","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1002301107","article-title":"Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection","author":"Takahashi","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cyto.2012.06.015_b0345","doi-asserted-by":"crossref","unstructured":"M.T. Dill, Z. Makowska, F.H.T. Duong, F. Merkofer, M. Filipowicz, T.F. Baumert, L. Tornillo, L. Terracciano, M.H. Heim, Interferon-\u03b3 Stimulated Genes, but not USP18, are Expressed in Livers of Patients with Acute Hepatitis C, Gastroenterology, (2012).","DOI":"10.1053\/j.gastro.2012.05.044"},{"key":"10.1016\/j.cyto.2012.06.015_b0350","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature07106","article-title":"Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA","volume":"454","author":"Saito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2012.06.015_b0355","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2012.06.015_b0360","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3","volume":"122","author":"Seth","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2012.06.015_b0365","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1243","article-title":"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction","volume":"6","author":"Kawai","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2012.06.015_b0370","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.molcel.2005.08.014","article-title":"VISA is an adapter protein required for virus-triggered IFN-beta signaling","volume":"19","author":"Xu","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.cyto.2012.06.015_b0375","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.23426","article-title":"Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system","volume":"51","author":"Bellecave","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0380","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2012.06.015_b0385","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.4049\/jimmunol.169.12.6668","article-title":"Cutting edge: a novel Toll\/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling","volume":"169","author":"Yamamoto","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.06.015_b0390","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.06.015_b0395","doi-asserted-by":"crossref","first-page":"e27552","DOI":"10.1371\/journal.pone.0027552","article-title":"Innate host response in primary human hepatocytes with hepatitis C virus infection","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2012.06.015_b0400","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2012.06.015_b0405","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.cyto.2012.06.015_b0410","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.cyto.2012.06.015_b0415","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2012.06.015_b0420","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-\u03bb and interferon-stimulated genes in primary liver cultures","volume":"54","author":"Marukian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0425","doi-asserted-by":"crossref","first-page":"13779","DOI":"10.1128\/JVI.78.24.13779-13792.2004","article-title":"Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees","volume":"78","author":"Bigger","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0430","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jhep.2011.07.017","article-title":"Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients","volume":"56","author":"Jouan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2012.06.015_b0435","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0440","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.cyto.2012.06.015_b0445","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0450","doi-asserted-by":"crossref","first-page":"e3442","DOI":"10.1371\/journal.pone.0003442","article-title":"Hepatic transcriptome analysis of hepatitis c virus infection in chimpanzees defines unique gene expression patterns associated with viral clearance","volume":"3","author":"Nanda","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cyto.2012.06.015_b0455","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1128\/JVI.01205-10","article-title":"Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences","volume":"84","author":"Yu","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.cyto.2012.06.015_b0460","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cyto.2012.06.015_b0465","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2012.06.015_b0470","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2006.08.043","article-title":"Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection","volume":"131","author":"Randall","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2012.06.015_b0475","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.24262","article-title":"Treatment failure and resistance with direct-acting antiviral drugs against hepatitis C virus","volume":"53","author":"Pawlotsky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0480","doi-asserted-by":"crossref","first-page":"112S","DOI":"10.1002\/hep.510260720","article-title":"Side effects of alpha interferon in chronic hepatitis C","volume":"26","author":"Dusheiko","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0485","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2012.06.015_b0490","doi-asserted-by":"crossref","unstructured":"Zeuzem S. Emerge study group, pegylated interferon-lambda (pegIFN-lambda) shows superior viral response with improved safety and tolerability versus pegIFN-(alpha)-2a in HCV patients (G1\/2\/3\/4): EMERGE phase IIb through week 2011;12.","DOI":"10.1016\/S0168-8278(11)61362-7"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612002608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612002608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T23:31:27Z","timestamp":1687563087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466612002608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1043466612002608"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2012.06.015","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}